The authors summarize the status of hematopoietic stem and progenitor cell (HSPC) gene editing, focusing on efficiency, genomic integrity, and long-term engraftment ability related to available genetic editing platforms and HSPC delivery methods.
[Molecular Therapy]
7992332
{7992332:AAAAAAAA}
apa
50
1
166690
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
